MEDESIS PHARMA
6Patents
6Active
6Granted
43Portfolio score
Filing activity: Mar 24, 2011 → Jul 5, 2019 · 2 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9452136B2 | Reverse micelle system comprising nucleic acids and use thereof | Chemistry; Metallurgy | 1 | Active |
| US11278568B2 | In situ preparation of cyano-bridged metal nanoparticles within a biocompatible reverse micellar system | Human Necessities | 0 | Active |
| US10172954B2 | Use of a reverse-micellar system for delivering chelators of radionuclides and metals | Human Necessities | 0 | Active |
| US11793831B2 | Treatment and prevention of injury due to radiation exposure | Human Necessities | 0 | Active |
| US9592218B2 | Reverse micelle system comprising metal ions and use thereof | Human Necessities | 0 | Active |
| US8877237B2 | Reverse micelle system comprising nucleic acids and use thereof | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.